Other Health News Topics Other STDs
Drug-resistant Gonorrhea Makes its Way into North America
- Details
- Category: Other STDs
- Published on Wednesday, 20 February 2013 00:00
- Written by Cyd Nova
The first documented failure of oral treatment for gonorrhea in North America has been reported in Toronto. The article, Neisseria gonorrhoeae Treatment Failure and Susceptibility to Cefixime in Toronto, Canada, published in the January 9, 2013, Journal of the American Medical Association, provides support for growing concern surrounding the second most prevalent bacterial sexually transmitted infection in the world.
CDC Recommendation: Dual Treatment to Curb Tide of Drug-Resistant Gonorrhea
- Details
- Category: Other STDs
- Published on Tuesday, 14 August 2012 00:00
- Written by Cyd Nova
Increasing fears about the emergence of antibiotic resistant gonorrhea in the U.S. have prompted new treatment and surveillance recommendations from the Centers for Disease Control and Prevention (CDC). Gail Bolan, director of the agency's Division of STD Prevention, called the move "a critical pre-emptive strike to preserve the last effective treatment option." 
STD Report Shows Small Rise Overall, Higher Rates for People of Color, Young Gay Men
- Details
- Category: Other STDs
- Published on Friday, 18 November 2011 00:00
- Written by Press Release
Reported cases of gonorrhea rose slightly and syphilis declined somewhat during 2010, but the syphilis rate among young black men has increased dramatically over the past 5 years, largely driven by increases among men who have sex with men (MSM), according to the latest sexually transmitted disease (STD) surveillance report from the Centers for Disease Control and Prevention (CDC).
WHO Warns of Global Threat of Drug-resistant Gonorrhea
- Details
- Category: Other STDs
- Published on Friday, 08 June 2012 00:00
- Written by Liz Highleyman
Multidrug-resistant gonorrhea is a growing concern worldwide and millions of people may be at risk of running out of treatment options unless urgent action is taken, according to an alert issued this week by the World Health Organization (WHO).
Sexual Partners Should Get Expedited Treatment for Chlamydia and Gonorrhea
- Details
- Category: Other STDs
- Published on Thursday, 15 September 2011 00:00
- Written by Press Release
Male sexual partners of women diagnosed with chlamydia or gonorrhea should be prescribed antibiotics in an effort to prevent passing infections back and forth, according to new guidelines from the American College of Obstetricians and Gynecologists (ACOG).
Researchers Report Setbacks on Herpes Simplex Vaccine and Treatment
- Details
- Category: Herpes
- Published on Friday, 24 February 2012 00:00
- Written by Liz Highleyman
An experimental herpes simplex virus (HSV) vaccine partially protected women against infection with HSV type 1 but not type 2, according to a recent report in the New England Journal of Medicine. Another recent study found that antiviral treatment with acyclovir (Zovirax) or valacyclovir (Valtrex) did not prevent periodic HSV-2 reactivation and viral shedding.
Genital Herpes Virus Can Spread Despite Lack of Symptoms
- Details
- Category: Herpes
- Published on Saturday, 23 April 2011 05:17
- Written by Liz Highleyman
People without genital sores or other symptoms can still shed and transmit herpes simplex virus type 2 (HSV-2) during sex, according to a recent U.S. study. 
Gonorrhea May Become Untreatable Due to Resistance, Experts Warn
- Details
- Category: Other STDs
- Published on Friday, 10 February 2012 00:00
- Written by Liz Highleyman
Neisseria gonorrhoeae,the bacteria that cause gonorrhea, are becoming increasingly resistant to existing drugs and more difficult to treat in the U.S., public health experts warn in the February 9, 2012, New England Journal of Medicine.
Oral Tenofovir Does Not Reduce Herpes Virus Shedding
- Details
- Category: Herpes
- Published on Tuesday, 25 January 2011 12:55
- Written by Liz Highleyman
HIV positive people who took tenofovir (Viread, also in the Truvada and Atripla combination pills) as part of their antiretroviral regimen were no less likely to shed herpes simplex virus 1 or 2 (HSV-1 or HSV-2) than individuals using non-tenofovir regimens, according to research described in the January 14, 2011, issue of AIDS. These findings are notable because a recent microbicide study found that a tenofovir gel reduced the likelihood of HSV-2 infection.
Web Design and Development by